Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma

Digestive Surgery

Volumn 15, Issue 6, 1998, Pages 674-678

  Fan, Jia ^a   Tang, Zhao You ^a   Yu, Ye Qin ^a   Wu, Zhi Quan ^a   Ma, Zeng Chen ^a   Zhou, Xin Da ^a   Zhou, Jian ^a   Qiu, Shuang Jian ^a   Lu, Ji Zhen ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Liver cancer; Staged resection

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CISPLATIN; ETHIODIZED OIL; FLUOROURACIL; GELFOAM; IODINATED POPPYSEED OIL; MITOMYCIN; PHARMARUBICIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; RETROSPECTIVE STUDY; TUMOR NECROSIS; TUMOR VOLUME; VOMITING;

EID: 0031721544     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018676     Document Type: Article

References (15)

1. Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Taraka K, Shioyama Y, Terada M, Kimura M: Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995;19: 795-800.
2. Liu Q, Jia YC, Tian JM, Wang ZT, Ye H, Lu JP, Wang F, Yang JJ, Sun F, Chen D, Lin L, He J: Factors affecting survival of hepatic carcinoma patients and their clinical significance (in Chinese). Chin J Oncol 1996;18:359-361.
3. Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P: Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993;71:62-65.
4. Cheng LF, Wang ZQ, Cai FC, Zhang YH, Liu YD: Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemoembolization (in Chinese). Chin J Oncol 1996;18:362-365.
5. Arii S, Okamoto E, Imamura M: Registries in Japan: Current status of hepatocellular carcinoma in Japan. Semin Surg Oncol 1996;12:204-211.
6. Group d'Etude et de Traitement du Carcinome Hépatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
7. Lehnert T, Herfarth C: Chemoembolization for hepatocellular carcinoma, what, when, and for whom? Ann Surg 1996;224:1-3.
8. Wang YH, Lin YX, Feng YQ, Ji XL, Zhao HL: Secondary resection of primary liver carcinoma after transcatheter hepatic arterial embolization (TAE): Clinicopathological features and postoperative course of 33 cases (in Chinese). J Hepatobiliary Pancr Splenic Surg 1997;3:68-73.
9. Tang ZY, Yu YQ, Zhou XD, Yang BH, Lin ZY, Lu JZ, Ma ZC, Ye SL, Liu KD: Three decades' experience in surgery of hepatocellular carcinoma. Chin Med J 1997;110:245-249.
10. Yu YQ, Tang ZY, Ma ZC, Zhou XD, Lu JZ: Resection of the primary liver tumour at the hepatic hilus. Cancer 1991;67:1322-1325.
11. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang R, Lu JZ, Lin ZY, Yang BH: Surgery of small hepatocellular carcinoma - Analysis of 144 cases. Cancer 1989;64:536-541.
12. Farinati F, De Maria N, Marafin C, Herszenyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R: Unresectable hepatocellular carcinoma in cirrhosis: Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 1996;41:2332-2339.
13. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY: Pulmonary metastasis of hepatocellular carcinoma assoicated with transarterial chemoembolization. J Hepatol 1995;23:563-568.
14. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, Peng FK: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg 1995; 82:122-126.
15. Belli L, Magistetti G, Puricclli GP, Damiani G, Colombo E, Cornalba GP: Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol 1997;7:323-326.